Journal of Microbiology

Review

Fecal Microbiota Transplantation: Indications, Methods, and Challenges.: Jee Young Lee, Yehwon Kim, Jiyoun Kim, Jiyeun Kate Kim; J. Microbiol. 2024;62(12):1057-1074. Published online November 18, 2024; DOI: https://doi.org/10.1007/s12275-024-00184-3

410 View
8 Download
2 Web of Science
8 Crossref

Over the past two decades, as the importance of gut microbiota to human health has become widely known, attempts have been made to treat diseases by correcting dysbiosis of gut microbiota through fecal microbiota transplantation (FMT). Apart from current knowledge of gut microbiota, FMT to treat disease has a long history, from the treatment of food poisoning in the fourth century to the treatment of Clostridioides difficile infections in the twentieth century. In 2013, FMT was recognized as a standard treatment for recurrent C. difficile because it consistently showed high efficacy. Though recurrent C. difficile is the only disease internationally recognized for FMT efficacy, FMT has been tested for other diseases and shown some promising preliminary results. Different FMT methods have been developed using various formulations and administration routes. Despite advances in FMT, some issues remain to be resolved, such as donor screening, manufacturing protocols, and unknown components in the fecal microbiota. In this review, we discuss the mechanisms, clinical indications, methods, and challenges of current FMT. We also discuss the development of alternative therapies to overcome the challenges of FMT.

Citations

Citations to this article as recorded by

Transplantation of Fecal Flora from Patients with Atherosclerosis to Mice Can Increase Serum Low-Density Lipoprotein Cholesterol and Affect Intestinal Flora and Its Metabolites
Liang Feng, Jianting Feng, Li He, Fu Chen, Xin Feng, Suwen Wang
Applied Microbiology.2025; 5(1): 29. CrossRef
Management of refractory checkpoint inhibitor-induced colitis
Anas Zaher, Maria Julia Moura Nascimento Santos, Hassan Elsaygh, Stephen J. Peterson, Carolina Colli Cruz, Anusha Shirwaikar Thomas, Yinghong Wang
Expert Opinion on Drug Safety.2025; : 1. CrossRef
Fecal Microbiota Transplantation (FMT) in Clostridium difficile Infection: A Paradigm Shift in Gastrointestinal Microbiome Modulation
Muhammad Hamza Saeed, Sundas Qamar, Ayesha Ishtiaq, Qudsia Umaira khan, Asma Atta, Maryam Atta, Hifza Ishtiaq, Marriam Khan, Muhammad Rawal Saeed, Ayesha Iqbal
Cureus.2025;[Epub] CrossRef
Exploring the gut microbiome’s influence on cancer-associated anemia: Mechanisms, clinical challenges, and innovative therapies
Ayrton Bangolo, Behzad Amoozgar, Maryam Habibi, Elizabeth Simms, Vignesh K Nagesh, Shruti Wadhwani, Nikita Wadhwani, Auda Auda, Daniel Elias, Charlene Mansour, Robert Abbott, Nisrene Jebara, Lili Zhang, Sarvarinder Gill, Kareem Ahmed, Andrew Ip, Andre Goy
World Journal of Gastrointestinal Pharmacology and Therapeutics.2025;[Epub] CrossRef
Microbiome Therapeutics for Clostridioides difficile Infection
Christine W. Lucky, Brendan J. Kelly, Jennie H. Kwon, Michael H. Woodworth, Rachel L. Medernach
Infectious Disease Clinics of North America.2025;[Epub] CrossRef
Laboratory preparation methods for human-derived fecal microbial suspensions for fecal microbiota transplantation: a review and standardization perspectives
Jinhua Gong, Yuchi Liu, Liuye Huang
Frontiers in Microbiology.2025;[Epub] CrossRef
Improving fecal transplantation precision for enhanced maturation of intestinal function in germ-free mice through microencapsulation and probiotic intervention
Furong Ba, Wei Wang, Yilun Huang, Shuobo Zhang, Bo Qiu, Siyuan Xie, Lvwan Xu, Wang Gao, Xiaoqin Zhang, Zhenyu Wen, Qifan Wang, Hainv Gao, Guoping Sheng, Björn Berglund, Ping Li, Lanjuan Li, Mingfei Yao
Microbiome.2025;[Epub] CrossRef
Fecal microbiota transplantation as salvage therapy for disseminated strongyloidiasis in an immunosuppressed patient: a case report
Wei Fu, Na Peng, Yan Geng
Frontiers in Immunology.2025;[Epub] CrossRef

First
Prev
Page of 1
Next
Last

Search